Those with HBsAg loss were predominantly male, urban employees, taking antiviral treatments (specifically IFN), had a longer HBV duration since infection, and had higher levels of ALT, AST, DBIL, ALB, GGT and LSM. The gene discussed is IFNA1; the disease is infection.